Clarinex-d 12 Hour
NDC Package 0085-1322-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Clarinex-d 12 Hour is a medication used to relieve allergy symptoms such as watery eyes, runny/stuffy nose, itching eyes/nose, and sneezing. Marketed by Merck Sharp & Dohme Corp., this product is identified by NDC 0085-1322 and is authorized under FDA application NDA021313.

Identification & Billing

NDC Package Code
0085-1322-01
Package Description
100 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC
Product Code
0085-1322
11-Digit Billing Format
00085132201
Billing Unit
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
Units Per Package
100 EA

Clinical Specifications

Proprietary Name
Clarinex-d 12 Hour
Dosage Form
-
Usage Information
This medication is used to relieve allergy symptoms such as watery eyes, runny/stuffy nose, itching eyes/nose, and sneezing. It contains 2 medications: desloratadine and pseudoephedrine. Desloratadine is an antihistamine and works by blocking a certain natural substance (histamine) that your body makes during an allergic reaction. Pseudoephedrine is a decongestant and works by narrowing the blood vessels in the nose to decrease swelling and congestion. This medication is not recommended for use in children younger than 12 years of age due to the large amount of pseudoephedrine in it.

Regulatory & Marketing

Labeler Name
Merck Sharp & Dohme Corp.
FDA Application #
NDA021313
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
02-01-2006
End Marketing Date
12-31-2021
Listing Expiration
12-31-2021
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 0085-1322-01 identifies a specific commercial package of 100 tablet, extended release in 1 bottle, plastic of Clarinex-d 12 Hour, labeled by Merck Sharp & Dohme Corp.. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Merck Sharp & Dohme Corp. on February 01, 2006. The current certification is valid through December 31, 2021.

What are the primary indications for this medication?

This medication is used to relieve allergy symptoms such as watery eyes, runny/stuffy nose, itching eyes/nose, and sneezing. It contains 2 medications: desloratadine and pseudoephedrine. Desloratadine is an antihistamine and works by blocking a certain natural substance (histamine) that your body makes during an allergic reaction. Pseudoephedrine is a decongestant and works by narrowing the blood vessels in the nose to decrease swelling and congestion. This medication is not recommended for use in children younger than 12 years of age due to the large amount of pseudoephedrine in it.

How is this Merck Sharp & Dohme Corp. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 00085132201. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 100 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (4-4-2)
0085-1322-01
11-Digit CMS (5-4-2)
00085-1322-01

Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.